474 related articles for article (PubMed ID: 18691763)
1. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
[TBL] [Abstract][Full Text] [Related]
2. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
[TBL] [Abstract][Full Text] [Related]
3. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
[TBL] [Abstract][Full Text] [Related]
5. Integration of activatory and inhibitory signals in human B-cells.
Sármay G; Koncz G; Gergely J
Immunol Lett; 1996 Dec; 54(2-3):93-100. PubMed ID: 9052860
[TBL] [Abstract][Full Text] [Related]
6. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
[TBL] [Abstract][Full Text] [Related]
7. Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19.
Szili D; Cserhalmi M; Bankó Z; Nagy G; Szymkowski DE; Sármay G
MAbs; 2014; 6(4):991-9. PubMed ID: 24828435
[TBL] [Abstract][Full Text] [Related]
8. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
9. FcgammaRIIB-mediated inhibition of T-cell receptor signal transduction involves the phosphorylation of SH2-containing inositol 5-phosphatase (SHIP), dephosphorylation of the linker of activated T-cells (LAT) and inhibition of calcium mobilization.
Jensen WA; Marschner S; Ott VL; Cambier JC
Biochem Soc Trans; 2001 Nov; 29(Pt 6):840-6. PubMed ID: 11709085
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
Sármay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
[TBL] [Abstract][Full Text] [Related]
12. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.
Haga CL; Ehrhardt GR; Boohaker RJ; Davis RS; Cooper MD
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9770-5. PubMed ID: 17522256
[TBL] [Abstract][Full Text] [Related]
13. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling.
Liu Q; Oliveira-Dos-Santos AJ; Mariathasan S; Bouchard D; Jones J; Sarao R; Kozieradzki I; Ohashi PS; Penninger JM; Dumont DJ
J Exp Med; 1998 Oct; 188(7):1333-42. PubMed ID: 9763612
[TBL] [Abstract][Full Text] [Related]
14. The dynamics of protein kinase B regulation during B cell antigen receptor engagement.
Astoul E; Watton S; Cantrell D
J Cell Biol; 1999 Jun; 145(7):1511-20. PubMed ID: 10385529
[TBL] [Abstract][Full Text] [Related]
15. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
Preissler MT; Kaiser L; Drake JR; Gosselin EJ
Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor.
Georgescu MT; Moorehead PC; Liu T; Dumont J; Scott DW; Hough C; Lillicrap D
Front Immunol; 2020; 11():138. PubMed ID: 32117285
[TBL] [Abstract][Full Text] [Related]
17. FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells.
Pauls SD; Ray A; Hou S; Vaughan AT; Cragg MS; Marshall AJ
J Immunol; 2016 Sep; 197(5):1587-96. PubMed ID: 27456487
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
[TBL] [Abstract][Full Text] [Related]
19. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
20. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
